WCBP Symposium 2024 – FDA California Separation Science Society (CaSSS) Interface of Regulatory and Analytical Sciences for Biotechnology Health Products (from Catapult’s regulatory round-up – December 2023)
The Symposium, organised by CASSS & FDA will be held on 23-25 of January 2024 in Washington D.C. It addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. The topics include CMC development strategies, innovative analytical characterization, global submission strategies, next-generation therapeutics & vaccines, as well as the challenges and promises of CRISPR-based therapeutics, which are poised to revolutionize the future of medicine. Please find further details including agenda and how to register here.
Published on the 5th of January 2024. Read the entire regulatory round-up for December 2023 here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (7 août 2024). WCBP Symposium 2024 – FDA California Separation Science Society (CaSSS) Interface of Regulatory and Analytical Sciences for Biotechnology Health Products (from Catapult’s regulatory round-up – December 2023). ELSIBI. Consulté le 7 octobre 2026 à l’adresse https://doi.org/10.58079/1258r
